300451.SZ
创业慧康
SZSE · Healthcare · I 信息技术 · CN
CNY 3.40
−1.45%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 958.7M | 1.1B | 1.4B | 1.6B | 1.5B |
| Cost of Revenue | 657.7M | 677.0M | 779.9M | 856.8M | 772.9M |
| Gross Profit | 301.0M | 374.7M | 642.7M | 759.1M | 754.2M |
| Operating Expenses | |||||
| R&D Expense | 291.3M | 295.6M | 269.3M | 247.5M | 217.8M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 190.3M | 199.2M | 209.1M | 207.6M | 189.1M |
| Selling & Marketing Expense | 85.5M | 88.5M | 120.7M | 129.3M | 116.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 569.5M | 585.3M | 569.6M | 585.8M | 516.6M |
| Cost and Expenses | 1.2B | 1.3B | 1.3B | 1.4B | 1.3B |
| Operating Income (EBIT) | (475.6M) | (414.3M) | (163.0M) | 43.7M | 52.9M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (476.9M) | (415.6M) | (161.5M) | 45.4M | 55.4M |
| Income Tax Expense | (23.4M) | (25.1M) | 5.8M | (318.8K) | 14.2M |
| Bottom Line | |||||
| Net Income | (465.5M) | (401.7M) | (173.5M) | 36.7M | 42.6M |
| Earnings from Cont. Ops | (453.5M) | (390.5M) | (167.3M) | 45.7M | 41.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (465.5M) | (401.7M) | (173.5M) | 36.7M | 42.6M |
| Per Share | |||||
| Basic EPS | (CN¥0.30) | (CN¥0.26) | (CN¥0.11) | CN¥0.02 | CN¥0.03 |
| Diluted EPS | (CN¥0.30) | (CN¥0.26) | (CN¥0.11) | CN¥0.02 | CN¥0.03 |
| Revenue Per Share | CN¥0.60 | CN¥0.68 | CN¥0.90 | CN¥0.88 | CN¥1.07 |
| Shares | |||||
| Basic Shares Outstanding | 1.6B | 1.5B | 1.6B | 1.8B | 1.4B |
| Diluted Shares Outstanding | 1.6B | 1.5B | 1.6B | 1.8B | 1.4B |
| Profitability Metrics | |||||
| EBITDA | — | (240.7M) | (13.6M) | 166.1M | 140.0M |
| D&A | — | 173.6M | 149.4M | 122.4M | 87.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026